Genepoint Technologies, established in 2015, is making strides in the Health Care industry by focusing on groundbreaking solutions for bio-sample storage management. Their commitment to innovation is encapsulated in their slogan: "Dedicated to developing and producing innovative, automated and intelligent solutions for bio-sample storage management." Reflecting a fast-evolving landscape where automation and intelligence are key drivers, the company positions itself as a pivotal player in enhancing storage efficiency and accuracy.
In its latest funding round, Genepoint Technologies secured a CNY200.00M Series D investment on 18 January 2023. This investment round witnessed participation from noteworthy investors such as Dyee Capital, LYFE Capital, Acusea/Huiyuan Capital, Guolian Capital, Guosheng Group, Beijing Guangda Huitong Engineering Technology Research Institute, and Guofang Capital. Such backing underscores robust investor confidence and highlights the company’s potential for continued growth and industry impact.
